CAS登录号 | 中文名 | 英文名 | 分子结构式 | 分子式 | 详情 | 供应商 |
67-42-5 | 乙二醇双(2-氨基乙基醚)四乙酸; 3,6-二氧杂-1,8-辛二胺四乙酸 | EGTA; Aceticacid, [ethylenebis(oxyethylenenitrilo)]tetra- (6CI,8CI); 1,2-Bis(2-aminoethoxyethane)-N,N,N',N'-tetraacetic acid; 2,2'-Ethylenedioxybis(ethylamine)-N,N,N',N'-tetraacetic acid; 3,12-Bis(carboxymethyl)-6,9-dioxa-3,12-diazatetradecanedioic acid; 3,6-DiOxaoctane-1,8-diamine-N,N,N',N'-tetraacetic acid; Chelest GEA; EBONTA; EDGA; EGTA; Egtazic acid; Ethylene glycol bis(2-aminoethylether)-N,N,N',N'-tetraacetic acid; Ethylene glycol bis(b-aminoethylether)-N,N,N',N'-tetraacetic acid; GEDTA; NSC 615010; O,O'-Bis(2-aminoethyl)ethylene glycol-N,N,N',N'-tetraacetic acid; [Ethylenebis(oxyethylenenitrilo)]tetraacetic acid | C14H24N2O10 | 详情 | 供应商 | |
134978-97-5 | 2-(2-(2-氨基乙氧基)乙氧基)乙酸 | 2-(2-(2-Aminoethoxy)ethoxy)acetic acid; Acetic acid,[2-(2-aminoethoxy)ethoxy]- (9CI); 8-Amino-3,6-diOxaoctanoic acid; NSC 626945; [2-(2-Aminoethoxy)ethoxy]acetic acid | C6H13NO4 | 详情 | 供应商 | |
166108-71-0 | [2-[2-(Fmoc-氨基)乙氧基]乙氧基]乙酸; [2-[2-(芴甲氧羰基氨基)乙氧基]乙氧基]乙酸 | [2-[2-(Fmoc-amino)ethoxy]ethoxy]acetic acid; 8-(Fmoc-amino)-3,6-diOxaoctanoic acid; [2-[2-(9H-Fluoren-9-ylmethoxycarbonylamino)ethoxy]ethoxy]acetic acid | C21H23NO6 | 详情 | 供应商 | |
5197-62-6 | 2-氯乙氧基-2-乙氧基二乙醇 | 2-(2-(2-chloroethoxy)ethoxy)ethanol; 2-[(2-Chloroethoxy)ethoxy]ethanol; 2-[2-(2-Chloroethoxy)ethoxy]ethanol; 8-Chloro-3,6-dioxa-1-octanol; 8-Chloro-3,6-diOxaoctanol; Diethylene glycol mono(2-chloroethyl) ether; NSC2636; Triethylene glycol monochloride; Triethylene glycol monochlorohydrin | C6H13ClO3 | 详情 | 供应商 | |
16024-58-1 | 2-(2-(2-甲氧基乙氧基)乙氧基)乙酸 | Acetic acid,2-[2-(2-methoxyethoxy)ethoxy]-; Aceticacid, [2-(2-methoxyethoxy)ethoxy]- (8CI,9CI); (Methoxyethoxy)ethoxyacetic acid; 3,6,9-Trioxadecanoic acid; 8-Methoxy-3,6-diOxaoctanoic acid; [2-(2-Methoxyethoxy)ethoxy]acetic acid | C7H14O5 | 详情 | 供应商 | |
127785-69-7 | Aureobasidin I (9CI); AureobasidinA, 5-L-leucine-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine,cyclic peptide deriv.; Antibiotic R 106VIII; Cyclo[L-leucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl]; L-Valine, 3-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-leucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]- | C60H92N8O11 | 详情 | 供应商 | ||
55621-21-1 | Acetic acid,2,2'-[(1,1,2,2-tetrafluoro-1,2-ethanediyl)bis(oxy)]bis[2,2-difluoro-; PERFLUORO-3,6-DIOxaoctANE-1,8-DIOIC ACID | C6H2F8O6 | 详情 | 供应商 | ||
127785-67-5 | Aureobasidin F (9CI); AureobasidinA, 6-L-valine-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine,cyclic peptide deriv.; Antibiotic R 106V; Cyclo[L-alloisoleucyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl]; L-Valine, 3-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]- | C59H90N8O11 | 详情 | 供应商 | ||
72469-41-1 | Acetamide,2-[2-[2-(dioctadecylamino)-2-oxoethoxy]ethoxy]-N,N-dipropyl-; ETH 322; N,N-Dioctadecyl-N',N'-dipropyl-3,6-diOxaoctanediamide | C48H96N2O4 | 详情 | 供应商 | ||
141754-60-1 | Acetamide,2,2'-[1,2-ethanediylbis(oxy)]bis[N,N-didodecyl- (9CI); ETH 5428; N,N,N',N'-Tetradodecyl-3,6-diOxaoctanediamide | C54H108N2O4 | 详情 | 供应商 | ||
127785-66-4 | Aureobasidin E (9CI); AureobasidinA, 3-(erythro-b-hydroxy-N-methyl-L-phenylalanine)-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine,cyclic peptide deriv.; Antibiotic R 106-IV; Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-(bS)-b-hydroxy-N-methyl-L-phenylalanyl-L-prolyl]; L-Valine,3-hydroxy-N-[N-[N-[N-[1-[erythro-b-hydroxy-N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]-; R 106-4 | C60H92N8O12 | 详情 | 供应商 | ||
23243-68-7 | Acetic acid,2,2'-[1,2-ethanediylbis(oxy)]bis-; Aceticacid, (ethylenedioxy)di- (7CI,8CI); (Ethylenedioxy)diacetic acid; 1,2-Bis(carboxymethoxy)ethane; 2,5-Dioxa-1,6-hexanedicarboxylic acid; 3,6-DiOxaoctane-1,8-dioic acid; 3,6-DiOxaoctanedioic acid; Ethylenebis(glycolic acid); NSC 8854; Triglycolic acid; [2-(Carboxymethoxy)ethoxy]acetic acid | C6H10O6 | 详情 | 供应商 | ||
127757-31-7 | Aureobasidin G (9CI); AureobasidinA, 8-(N-methyl-L-valine)-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine,cyclic peptide deriv.; Antibiotic R 106VI; Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl]; L-Valine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]- | C60H92N8O10 | 详情 | 供应商 | ||
127757-32-8 | Aureobasidin K (9CI); AureobasidinA,1-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valine]-8-(N-methyl-L-valine)-,(R)-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine,cyclic peptide deriv.; Antibiotic R 106Xa; Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl]; L-Valine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, (R)- | C59H90N8O10 | 详情 | 供应商 | ||
158313-51-0 | Aureobasidin T2 (9CI); AureobasidinA, 6-(N-methyl-L-leucine)-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine,cyclic peptide deriv.; Cyclo[L-alloisoleucyl-N-methyl-L-leucyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl] | C61H94N8O11 | 详情 | 供应商 | ||
127757-30-6 | Aureobasidin D (9CI); AureobasidinA, 8-(4-hydroxy-N-methyl-L-valine)-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine,cyclic peptide deriv.; Antibiotic R 106III; Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-4-hydroxy-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl]; L-Valine, 4-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone | C60H92N8O11 | 详情 | 供应商 | ||
127757-34-0 | Aureobasidin Q (9CI); AureobasidinA, 8-(N-methyl-L-phenylalanine)-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine,cyclic peptide deriv.; Antibiotic R 106XV; Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-phenylalanyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl]; L-Phenylalanine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]- | C64H92N8O10 | 详情 | 供应商 | ||
158412-72-7 | Aureobasidin T1 (9CI); AureobasidinA, [R-(R*,S*)]-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine,cyclic peptide deriv.; Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R,3S)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl] | C60H92N8O11 | 详情 | 供应商 | ||
127939-17-7 | Aureobasidin B (9CI); AureobasidinA, 1-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valine]-, (R)-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine,cyclic peptide deriv.; Antibiotic R 106IIa; Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-3-hydroxy-N-methyl-L-valyl-(2R)-2-hydroxy-3-methylbutanoyl-N-methyl-L-valyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-prolyl]; L-Valine, 3-hydroxy-N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxobutyl)-N-methyl-L-valyl]-L-phenylalanyl]-N-methyl-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, (R)- | C59H90N8O11 | 详情 | 供应商 | ||
127785-71-1 | Aureobasidin M (9CI); AureobasidinA, 3-L-phenylalanine-8-(N-methyl-L-valine)-; 1H,15H-Pyrrolo[1,2-m][1,4,7,10,13,16,19,22,25]Oxaoctaazacycloheptacosine, cyclicpeptide deriv.; Antibiotic R 106XI; Cyclo[L-alloisoleucyl-N-methyl-L-valyl-L-leucyl-N-methyl-L-valyl-(2R,3R)-2-hydroxy-3-methylpentanoyl-N-methyl-L-valyl-L-phenylalanyl-L-phenylalanyl-L-prolyl]; L-Valine, N-[N-[N-[N-[1-[N-[N-[N-(2-hydroxy-3-methyl-1-oxopentyl)-N-methyl-L-valyl]-L-phenylalanyl]-L-phenylalanyl]-L-prolyl]-L-alloisoleucyl]-N-methyl-L-valyl]-L-leucyl]-N-methyl-,a1-lactone, [R-(R*,R*)]- | C59H90N8O10 | 详情 | 供应商 |